Evidence map›Paper›PMID 29783095›Full record

Trial reportDrug and alcohol dependence2018

Initiating buprenorphine treatment prior to versus after release from prison: Arrest outcomes.

Michael S Gordon, Thomas R Blue, Kathryn Couvillion, Robert P Schwartz, Kevin E O'Grady, Terrence T Fitzgerald, Frank J Vocci

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Drug and alcohol dependence, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Routes of non-traditional entry into buprenorphine treatment programs.Substance abuse treatment, prevention, and policy · 2020
    Pooled it
  4. Interventions for female drug-using offenders.The Cochrane database of systematic reviews · 2019
    Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michael S GordonFriends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD 21201, USA. Electronic address: mgordon@friendsresearch.org.
Thomas R BlueFriends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD 21201, USA.
Kathryn CouvillionFriends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD 21201, USA.
Robert P SchwartzFriends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD 21201, USA.
Kevin E O'GradyDepartment of Psychology, University of Maryland, 4094 Campus Dr., College Park, MD 20742, USA.
Terrence T FitzgeraldGlenwood Life Counseling Center, 516 Glenwood Ave, Baltimore, MD 21212, USA.
Frank J VocciFriends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD 21201, USA.

Funding

Buprenorphine for PrisonersR01DA021579 · NIDA · FRIENDS RESEARCH INSTITUTE, INC. · PI KINLOCK, TIMOTHY W · 2007 to 2011
$2.7M
NIDA NIH HHS R01 DA021579
6 · The paper itself

Abstract

backgroundThis secondary analysis of a randomized trial examines the association between initiation of buprenorphine treatment prior to, versus post-release, and rearrests during the 12-months following release.

methodsOfficial rearrest data (N = 199) for the 12-months post-release were examined. Four outcomes were measured: (1) rearrested (yes/no), (2) time to rearrest, (3) number of rearrests, and (4) severity of charges (less severe vs. severe).

resultsA minority (43.1%) of the sample were rearrested (N = 91). There were no significant differences between study conditions in the proportion of rearrested participants [P = 0.28] nor in the mean number of arrests [P  = 0.15]. Likewise, the condition was not a significant predictor of the hazard of rearrest [p = 0.10]. The mean number of days until rearrest for the in prison vs. post-release buprenorphine conditions were not significantly different (205.8 days (SD  = 104.6) vs. 170.8 days (SD  = 113.1), respectively; P  = 0.13]. Treatment condition was not a significant predictor of the likelihood of rearrest for a severe crime compared to a less severe crime [P  = 0.09].

conclusionDespite the parent study finding of higher rates of post-release drug treatment entry in the group assigned to start buprenorphine treatment prior to, compared to post-release, there were no significant differences in the proportion of individuals arrested, the mean number of arrests, the time to first arrest, or the severity of their charges.

Indexed as

AdultBuprenorphineCrimeFemaleHumansLaw EnforcementMaleMiddle AgedOpiate Substitution TreatmentOpioid-Related DisordersPrisonersTime FactorsBuprenorphineBuprenorphine treatmentCriminal activityOfficial arrest recordsOpioid use disorderPrisoners

Identifiers

PMID29783095
PMCPMC5999574

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.